TOPAZ - Clinical Trial of Parkinson's Disease and Zoledronic Acid

Stony Brook University is looking for individuals with Parkinson’s disease for a research study endorsed by the Parkinson’s Foundation and the Parkinson’s Study Group. The purpose of the study is to test the medication, zoledronic acid, to see if it can help prevent fractures in people with Parkinson’s Disease.

As part of this study, a nurse will come to your home to give you a short exam. You will receive a one-time dose of the study treatment and will be contacted every four months to check if you have had any new fractures. Individuals with Parkinson’s disease between the ages of 65 or older are invited to participate. Participants will be a provided with a small stipend for enrollment and yearly during the study.

To learn more about joining this study you can call the Parkinson’s Foundation Helpline at 1-800-4PD-INFO (473-4636) or if you are ready to enroll visit www.topazstudy.org and enter STONYBROOK as your invitation code.